A detailed history of Keybank National Association transactions in Veracyte, Inc. stock. As of the latest transaction made, Keybank National Association holds 7,265 shares of VCYT stock, worth $247,809. This represents 0.0% of its overall portfolio holdings.

Number of Shares
7,265
Holding current value
$247,809
% of portfolio
0.0%

Shares

4 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q4 2024

Feb 06, 2025

BUY
$31.92 - $44.4 $231,898 - $322,566
7,265 New
7,265 $287,000
Q2 2021

Aug 12, 2021

SELL
$32.94 - $56.62 $134,526 - $231,236
-4,084 Closed
0 $0
Q1 2021

May 07, 2021

SELL
$44.47 - $81.38 $8,093 - $14,811
-182 Reduced 4.27%
4,084 $220,000
Q4 2020

Feb 09, 2021

BUY
$32.49 - $61.88 $138,602 - $263,980
4,266 New
4,266 $209,000

Others Institutions Holding VCYT

About VERACYTE, INC.


  • Ticker VCYT
  • Exchange NASDAQ
  • Sector Healthcare
  • Industry Biotechnology
  • Shares Outstandng 71,575,904
  • Market Cap $2.44B
  • Description
  • Veracyte, Inc. operates as a diagnostics company worldwide. The company offers Afirma Genomic Sequencing Classifier and Xpression Atlas, which are used to determine patients with indeterminate results are benign to avoid unnecessary surgery; Decipher Prostate Biopsy and Radical Prostatectomy for prostate cancer diagnosis; Prosigna Breast Cancer ...
More about VCYT
Track This Portfolio

Track Keybank National Association Portfolio

Follow Keybank National Association and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Keybank National Association, based on Form 13F filings with the SEC.

News

Stay updated on Keybank National Association with notifications on news.